glycopyrrolate Tablets 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
Canada
Unavailable markets
Peru
Available for
Licensing with supply, Distribution only
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 2 days